Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

A novel series of compounds was designed and synthesized by combining the distal piperazine nitrogen of the antifungal ketoconazole (KTZ) with primary arylsulfonamides. The aim of this study is to present the basis for a new generation of Malassezia antifungal agents able to inhibit the enzyme lanosterol-14α-demethylase (CYP51; EC 1.14.13.70) as well as a newly emergent therapeutic target: carbonic anhydrases (CAs; EC 4.2.1.1). The final compounds showed effective interactions with the intended targets in vitro, as well as KTZ comparable minimum inhibitory concentrations on yeast strains of the Malassezia genus: Malassezia furfur ATCC 14521; Malassezia globosa ATCC MYA 4612; and Malassezia pachydermatis DSM 6172. Overall, the data obtained account for the reported compounds as promising antifungal candidates with high safety profiles for the management of fungal infections.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12304870PMC
http://dx.doi.org/10.1002/ardp.70062DOI Listing

Publication Analysis

Top Keywords

malassezia
5
design synthesis
4
synthesis ketoconazole
4
ketoconazole derivatives
4
derivatives innovative
4
innovative anti-infective
4
anti-infective agents
4
agents novel
4
novel series
4
series compounds
4

Similar Publications

Convenient alternative synthesis of the -derived virulence factor malassezione and related compounds.

Beilstein J Org Chem

August 2025

Department of Biochemistry & Molecular Biology, Dalhousie University, Halifax, Nova Scotia, B3H 4R2, Canada.

Lipophilic yeasts of the genus are commensal fungi that constitute the normal skin microbiota but may become pathogenic. These fungi, especially , convert tryptophan into various alkaloid indoles such as malassezione, which may serve as virulence factors. To facilitate testing of malassezione as an aryl hydrocarbon receptor agonist and potential glucokinase activator, we developed a convenient synthetic route from commercially available indole-3-acetic acid.

View Article and Find Full Text PDF

Immunocompromised individuals are susceptible to cutaneous mycoses, often following skin trauma. Although infections by , , , , and are well-documented, human infection by unusual basidiomycetes is rarely reported. We describe a 69-year-old heart transplant recipient with a cutaneous nodule that was surgically excised and identified via fungal PCR as , a basidiomycete not previously implicated in human disease.

View Article and Find Full Text PDF

Background: We aimed to elucidate the cystic fibrosis (CF) microbiota composition (shotgun metagenomics) and functionality (short-chain fatty acids, SCFAs).

Methods: Fecal and sputum samples were recruited from 39 clinically stable CF subjects.

Results: Bacillota and Pseudomonadota were dominant in both gut and lung compartments, whereas Ascomycota were the most abundant fungi in feces, and Basidiomycota, especially Malassezia globosa, in sputum.

View Article and Find Full Text PDF

Metatranscriptomics methods for the skin are hampered by low microbial biomass, contamination with host cells and low RNA stability. In this study, we developed a robust, clinically tractable skin metatranscriptomics workflow that provides high technical reproducibility of profiles, uniform coverage across gene bodies and strong enrichment of microbial mRNAs. Paired application of this protocol with metagenomics to five skin sites in a cohort of 27 healthy adults identifies a notable divergence between transcriptomic and genomic abundances.

View Article and Find Full Text PDF

Infliximab (IFX), a first-line treatment for moderate to severe Crohn's disease (CD), has immunomodulatory effects that increase the risk of opportunistic infections. Although IFX-associated invasive fungal infections have received widespread attention, IFX-associated superficial cutaneous fungal infections, such as Malassezia folliculitis (MF), have not been fully recognized. Herein, we present a case of a 19-year-old female patient with moderately active CD who rapidly developed facial erythema, inflammatory papules, and nodular lesions after treatment with IFX.

View Article and Find Full Text PDF